HopeStage
Back to all studies
CompletedNCT00566150

Levetiracetam or placebo added to treatment for bipolarity depression

About this titleRead the official source — NCT00566150
Medication studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
New HavenSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2005
Recruitment status
Completed
Enrollment listed in the registry
35
Sponsor
Yale University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT00566150
Official title
Show the full official title

Levetiracetam in the Management of Bipolar Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Did this study involve medication?

Yes. The study involved medication, including Levetiracetam and Placebo.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies